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Article Information  ABSTRACT 
Received: 12th Feb 2017  The demand for MDT (Mouth Disintegrating Tablet) has been increasing from the last decade 
particularly in geriatric, pediatric and patient with some sort of disabilities in swallowing. MDTs 
are those tablets which when placed in mouth get dissolved rapidly in saliva without the need of 
liquid and can be swallowed. European pharmacopoeia adopted the term Orodispersible tablet 
for MDTs. Mouth disintegrating tablets are also known as Fast melting tablets, Orodispersible 
tablets, fast dissolving/dispersing tablets or melt in mouth tablets. This article reviews the 
potential benefits offered by MDTs as an oral drug delivery system for various kinds of patients 
suffering from different diseases and disabilities. Desired characteristics and challenges for 
developing fast disintegrating drug delivery systems, quality control tests, various techniques 
used in the preparation of fast disintegrating drug delivery systems like lyophilization 
technologies, tablet molding method, sublimation techniques, spray drying techniques, mass 
extrusion technology, direct compression method and uses of super-disintegrates. It also reviews 
the patented technologies for fast dissolving tablets, advantages and disadvantages of different 
technologies for preparing fast disintegrating dosage form, future prospective for MDTs. The 
growing importance for MDTs is due to the potential advantages offered by this technology. 
MDT is a New Drug Delivery system with least disintegration time and ease of self 
administration 
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INTRODUCTION 
Many patients, especially elderly find it difficult in swallowing 
tablets, capsules, fluids and thus do not comply with 
prescription, which results in high incidence of non-compliance 
oriented research has resulted in bringing out many safer and 
new drug delivery system. Rapidly disintegrating/dissolving 
tablet is one of such example, for the reason of rapid 
disintegration or even with saliva. Considering quality of life, 
most of these efforts have been focused on ease of medication. 
Among the various dosage forms developed to improve the 
ease of administration, the mouth dissolving tablet (MDT) is 
the most widely preferred commercial products. The oral cavity 
is an attractive site for the administration of drugs because of 
ease of administration. Various dosage forms like Tablets, 
Capsules, and Liquid preparations are administered by oral 
route. During the last decade, mouth dissolving tablet (MDT) 
technologies that make tablets disintegrate in the mouth 
without chewing and additional water intake have drawn a 
great deal of attention. The MDT is also known as fast melting, 
fast dispersing, rapid dissolve, rapid melt, and or quick 
disintegrating tablet. All MDTs approved by the Food and 
Drug Administration (FDA) are classified as orally 
disintegrating tablets. Recently, the European Pharmacopeia 
adopted the term orodispersible tablet for a tablet that disperses 
or disintegrates in less than 3minutes in the mouth before 
swallowing. Such a tablet disintegrates into smaller granules or 
melts in the mouth from a hard solid to a gel-like structure, 
allowing easy swallowing by patients. The disintegration time 
for good MDTs varies from several seconds to about a minute. 
Orally disintegrating tablets provide an advantage particularly 
for pediatric and geriatric population who has difficulty in 
swallowing conventional tablets and capsules. Additionally 
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pediatrics patients may suffer from ingestion problems as 
results of underdeveloped muscular and nervous control.  
 
Moreover, patients traveling with little or no excess to water, 
limit utility of orally administer convectional tablet capsule. 
MDT result in quick dissolution and rapid absorption which 
provide rapid onset of action. Moreover, drug candidates that 
undergo pre-gastrics absorption when formulated as MDTs 
may show increased oral bioavailability. It provides good 
stability accurate dosing, and easy manufacturing [1 – 4]  
 
Ideal Properties [2] 
An ideal MDT should:  
1) Require no water for oral administration.  
2) Have a pleasing mouth feel.  
3) Have an acceptable taste masking property.  
4) Be harder and less friable.  
5) Leave minimal or no residue in mouth after administration.  
6) Exhibit low sensitivity to environmental conditions 
(temperature and humidity).  
7) Allow tablet manufacturing by conventional processing and 
packaging equipments.  
 
Advantages [3] 
1) Administration to the patients who cannot swallow, such as 
the elderly, bedridden patients, patients affected by renal failure 
& patients who refuse to swallow such as pediatric, geriatric & 
psychiatric patients.  
2) Rapid drug therapy intervention.  
3) Achieve increased bioavailability/rapid absorption through 
pre-gastric absorption of drugs from mouth, pharynx & 
esophagus as saliva passes down.  
4) Convenient for administration and patient compliant for 
disabled, bedridden patients and for travelers and busy people, 
who do not always have access to water.  
5) The risk of chocking or suffocation during oral 
administration of conventional formulations due to physical 
obstruction is avoided, thus providing improved safety.  
6) New business opportunity will be getting generated due to 
the product differentiation.  
 
Salient Features [4] 
1) Ease of administration to patients who refuse to swallow a 
tablet, such as pediatric and geriatric patients and, psychiatric 
patients.  
2) Convenience of administration and accurate dosing as 
compared to liquids.  
3) Rapid dissolution of drug and absorption which may 
produce rapid, onset of action.  
4) Some drugs are absorbed from the pharynx and oesophagus 
as the saliva passes down into the stomach, in such cases 
bioavailability of drugs is increased.  
5) Ability to provide advantages of liquid medication in the 
form of solid preparation.  
6) Pre-gastric absorption can result in improved bioavailability 
and as a result of reduced dosage, improved clinical 
performance through a reduction of unwanted effects. 
 
Limitations of Mouth Dissolving Tablets 
[4]
: 
1) The tablets usually have insufficient mechanical strength. 
Hence, careful handling is required.  
2) The tablets may leave unpleasant taste and/or grittiness in 
mouth if not formulated properly.  
3) Drugs with relatively larger doses are difficult to formulate 
into MDT e.g. antibiotics like ciprofloxacin with adult 
dose tablet containing about 500 mg of the drug.  
4) Patients who concurrently take anticholinergic medications 
may not be the best candidates for MDT. Similarly patients 
with dryness of the mouth due to decreased saliva 
production may not be good candidates for these tablet 
formulations. 
  
Desired characteristics and challenges for developing fast 
disintegrating drug delivery systems: 
 
1) Time required for disintegration  
2) MDTs should disintegrate/dissolve/disperse or melt in 
mouth without the need of water in very short duration of time, 
possibly within 60 seconds.  
3) Taste of the active ingredient  
4) As most drugs are unpalatable, fast disintegrating drug 
delivery systems usually contain the medicament in taste-
masked form. Delivery systems dissolve or disintegrate in 
patient’s mouth, thus releasing the active ingredients which 
come in contact with the taste buds and hence, taste masking of 
the drugs becomes critical to patient compliance.  
5) Tablet strength, Friability and porosity: In order to allow 
fast disintegrating tablets to disintegrate in the mouth, they are 
made of either very porous or soft- moulded matrices or 
compressed into tablets with very low compression force, 
which makes the tablets friable and/or brittle, which are 
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difficult to handle, often requiring specialized peel-off blister 
packaging.  
6) Hygroscopic nature: Several fast disintegrating drug delivery 
dosage forms are hygroscopic and cannot maintain physical 
integrity under normal condition from humidity which calls for 
specialized product packaging. 
7) Mouth feel: Mouth feel is critical, and patients should 
receive a product that feels pleasant. Any large particles from 
the disintegrating tablet that are insoluble or slowly soluble in 
saliva would lead to an unpleasant gritty feeling. This can be 
overcome by keeping the majority of the particles below the 
detectable size limit. In some cases, certain flavors can imbibe 
an improved mouth feel perception, resulting in a product that 
is perceived as being less gritty, even if the only change is the 
flavor. Effervescence can be added to aid disintegration and 
improve mouth feel by reducing the “dryness” of a product [5]. 
 
Various techniques used in the preparation of mouth 
disintegrating drug delivery systems
 
1) Freeze–drying (Lyophilization technologies)  
2) Tablet molding method  
3) Sublimation techniques  
4) Spray drying techniques 
5) Mass extrusion technology  
6) Direct compression method  
7) Use of disintegrates 
 
1) Freeze drying or Lyophilization technology 
A process by which, water get sublimated from product after 
freezing. Lyophilization is a pharmaceutical technology which 
allows drying of heat sensitive drugs and biologicals at low 
temperature under conditions that allows removal of water by 
sublimation. Lyophilization results in preparations, which are 
highly porous, with a very high specific surface area, which 
dissolve rapidly and show improved absorption and 
bioavailability [6, 7]. R. P. Scherer patented Zydis technology 
by employing freeze drying process for the preparation of 
mouth dissolving tablet. On the basis of patent issued to 
Gregory et al. [8] Seager discussed formation, process 
technology & bioavailability of fast dissolving tablets prepared 
by using Zydis technology [8].  
 
2) Molding method 
Moulded tablets are prepared by using water-soluble 
ingredients so that the tablet dissolve or disintegrate rapidly 
and completely. Powder is moistened with the help of hydro 
alcoholic solvent and then moulded into tablets under pressure 
less than the conventional dosage form. The solvents are 
removed by air-drying. The tablet Possesses porous structure, 
which facilitates easy dissolution. Adding sucrose, acacia or 
PVP k30 may increase the mechanical strength of tablet [6, 7]. 
 
Drug + Matrix components 
 
Preparation of suspension 
  
 
Adjust dosing system to delivery correct weight of 
suspension 
 
 
Dosing of suspension into perform blisters 
 
 
Freeze blister travs and contents 
 
 
Collect and store frozen blister trav 
 
 
Subject blister trav to lyophilization 
 
 
Seal and pack blister (peeleable type blister ) 
Figure 1: Steps involved in freeze drying technology 
 
3) Sublimation method 
The basic principle involved in preparing fast dissolving tablets 
by sublimation technique is addition of a volatile salt to the 
tableting components, mixing the components to obtain a 
substantially homogeneous mixture & volatizing a volatile salt. 
The removal of volatile salts creates pores in the tablet, which 
help in achieving rapid disintegration when the tablet comes in 
contact with saliva. Camphor, Naphthalene, Urea, ammonium 
bicarbonate, etc, can be used to prepare porous tablets of good 
mechanical strength [6-7]. Koizumi et al. used mannitol as 
diluent and camphor as a volatile material to prepare porous 
compressed tablets [9]. The tablets were subjected to vacuum at 
80°C for 30 min to eliminate the camphor and thus form the 
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pores in the tablet. Makino et. al utilized water as a pore 
forming material in order to prepare porous tablets with 
excellent mechanical strength & dissolution character [6-7, 9].  
 
Figure No. 2: Steps involved in sublimation technology 
 
3) Spray drying method 
Spray drying is a process by which highly porous, fine powders 
can be produced. Spray-dryers are invariably used in the 
pharmaceutical industry to produce highly porous powders. 
Allen et al. have reported applying this process to the 
production of fast dissolving tablets [10]. Spray Drying can be 
used to prepare rapidly dissolving tablet. This technique is 
based upon a particulate support matrix that is prepared by 
spray drying and aqueous composition containing support 
matrix and other components to form a highly porous & fine 
powder. This is then mixed with active ingredient & 
compressed into tablet. Fast dissolving tablet prepared by spray 
drying technique disintegrated within 20 seconds [6-7, 10]. 
 
Patented technologies for mouth dissolving tablets [11] 
1) Zydis Technology: Zydis formulation is a unique freeze 
dried tablet in which drug is physically entrapped or dissolved 
within the matrix of fast dissolving carrier material.  When 
zydis units are put into the mouth, the freeze-dried structure 
disintegrates instantaneously and does not require water to aid 
swallowing. The zydis matrix is composed of many materials 
to achieve a number of objectives. To impart strength and 
resilience during handling, polymers such as gelatin, dextran or 
alginates are incorporated. These form a glossy amorphous 
structure, which imparts strength. To obtain crystallinity, 
elegance and hardness, saccharides such as mannitol or sorbitol 
are incorporated. Water is used in the manufacturing process to 
ensure production of porous units to achieve rapid 
disintegration while various gums are used to prevent 
sedimentation of dispersed drug particles in the manufacturing 
process. Collapse protectants such as glycine prevent the 
shrinkage of zydis units during freeze drying process or long-
term storage. Zydis products are packed in blister packs to 
protect the formulation from moisture in the environment [11].  
 
Preparation of aqueous composition of support matrix + bulking 
agent + volatizing agent + disintegrates + buffering agent                                                                                                                                                    
 
 
Aqueous composition introduced as droplet in a spray dryer 
 
 
Heated to predetermined temperature causing evaporation of all 
aqueous medium & volatizing agent from droplets 
 
 
Dried particulate support matrix 
 
 
Addition of active ingredient & other tablet excipients 
 
 
Compressed into tablet 
 
Rapidly dissolving Tablet 
Figure No. 3 Steps Involved spray drying method 
 
2) Durasolv Technology: Durasolv is the patented technology 
of CIMA labs. The tablets made by this technology consist of 
drug, filler and a lubricant. Tablets are prepared by using 
conventional tabletting equipment and have goodrigidity. 
These can be packaged into conventional packaging system 
like blisters. Durasolv is an appropriate technology for product 
requiring low amounts of active ingredients [11] 
 
3) Orasolv Technology: CIMA labs have developed Orasolv 
Technology. In this system active medicament is taste masked. 
It also contains effervescent disintegrating agent. Tablets are 
made by direct compression technique at low compression 
force in order to minimize oral dissolution time. Conventional 
blenders and tablet machine is used to produce the tablets. The 
tablets produced are soft and friable [11].  
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4) Flash Dose Technology: Flash dose technology has been 
patented by fuisz. Nurofen meltlet, a new form of ibuprofen as 
melt in mouth tablets prepared using flash dose technology is 
the first commercial product launched by Biovail Corporation. 
Flash dose tablets consist of selfbinding shear form matrix 
termed as “floss”.Shear form matrices are prepared byWOW 
means “Without Water”. In this process, combination of low 
mouldability saccharides and high mouldability saccharides is 
used to obtain a rapidly melting strong tablet. The active 
ingredient is mixed with a low mouldability saccharide (e.g. 
lactose, glucose, and mannitol) and granulated with a high 
mouldability saccharide (e.g. Maltose, oligosaccharides) [11] 
   
5) Flash tab Technology: Prographarm laboratories have 
patented the Flash tab technology. Tablet prepared by this 
system consists of an active ingredient in the form of micro 
crystals. Drug micro granules may be prepared by using the 
conventional techniques like coacervation, micro encapsulation 
and extrusion spheronisation. All the processing utilized 
conventional tablet technology [11] 
 
Super Disintegrants Used in MDTs 
As day’s passes, demand for faster disintegrating formulation is 
increased. So, pharmacist needs to formulate disintegrants i.e. 
Super disintegrants which are effective at low concentration 
and have greater disintegrating efficiency and they are more 
effective intragranularly. This super disintegrants act by 
swelling and due to swelling pressure exerted in the outer 
direction or radial direction, it causes tablet to burst or the 
accelerated absorption of water leading to an enormous 
increase in the volume of granules to promote disintegration 
[12]. Various types of Super disintegrants used are as follows –  
1) Crosspovidone  
2) Microcrystalline cellulose  
3) Sodium starch glycollate  
4) Sodium carboxy methyl cellulose /Cross carmelose sodium  
5) Crosscarmellose sodium  
6) Calcium carboxy methyl cellulose 
7) Modified corn starch 
8) Kyron   
 
Factors to be considered for selection of super disintegrants 
[12]  
1. It should produce mouth dissolving when tablet meets saliva 
in the mouth  
2. It should be compactable enough to produce lessfriable 
tablets.  It can able to produce good mouth feel to the patient. 
Thus, small particle size is preferred to achieve patient 
compliance. 
3. It should have good flow since it improve the flowability of 
the total blend.  
 
Evaluation of mouth dissolving tablets [13, 14] 
MDTs formulations have to be evaluated for the following 
evaluation test. 
1) General Appearance: The general appearance of tablets 
includes size, shape, color, taste, odour, surface texture. 
 
2) Size, Shape, Thickness and diameter: The size and shape 
of the tablet can be dimensionally described, monitored 
and controlled. Thickness of tablets is an important 
characteristic for appearance and also in counting by using 
filling equipment. Some filling equipment utilizes the 
uniform thickness of the tablets as a counting mechanism. 
Ten tablets should be taken and their thickness is required 
to measure by vernier caliper. 
 
3) Uniformity of weight: In Indian pharmacopoeia 
procedure for uniformity of weight was followed, ten or 
twenty tablets were taken and their weight was determined 
individually and collectively on a digital weighing balance. 
Then the average weight of one tablet is required to be 
finding out from collective weight. The weight variation 
test would be a satisfactory method of determining the 
drug content uniformity. 
 
4) Hardness of tablets: Hardness of tablet is defined as the 
force applied across the diameter of the tablet in the order 
to break the tablet. Resistance of the tablet to chipping, 
abrasion or breakage under condition of storage 
transformation and handling before usage depends on its 
hardness. Hardness of the tablet of each formulation was 
determined using Monsanto hardness tester. 
 
5) Friability of tablets: Friabilator consist of plastic chamber 
revolves at 25 rpm, dropping those tablets at distance of 6 
inches with each revolution. The tablets were rotated in the 
friabilator for at least 4 min. At the end of these test tablets 
are required to be dedusted and reweighed, the loss in the 
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weight of tablet is the measured of friability and is 
expressed in percentage as 
%𝑓𝑟𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 =
𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑤𝑒𝑖𝑔𝑕𝑡 − 𝑓𝑖𝑛𝑎𝑙 𝑤𝑒𝑖𝑔𝑕𝑡
𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑤𝑒𝑖𝑔𝑕𝑡
× 100 
 
6) Disintegration time: As described in pharmacopoeia, 
tablets are placed in the disintegration tube and time is 
noted. According to the European pharmacopoeia the fast 
disintegration or orodispersible tablets should disintegrate 
within 3 min without leaving any residue on the screen. 
 
7) In-vitro dispersion time test: To determine dispersion 
time take a 10ml of measuring cylinder and pour a 6ml of 
distill water in it, then drop a tablet in the same. Finally the 
time required for complete dispersion was determined as a 
dispersion time. 
 
8) Wetting time: Take five circular tissue papers of 10 cm 
diameter and placed them in a petridish with a 10 cm 
diameter. Ten millimeters of watercontaining Eosin, a 
water-soluble dye, is required to add in petridish. Then 
place a tablet carefully on the surface of the tissue paper. 
The time required for water to reach upper surface of the 
tablet is noted as a wetting time. 
  
9) Water absorption ratio: Fold a piece of tissue paper 
twice and place it in a small Petri dish containing 6 ml of 
water. Place a tablet on the paper & record the time 
required for complete wetting. Then note down the weight 
of a wetted tablet. Finally water absorption ratio (R), is 
find out using the following equation,  
𝑅 = 10  
𝑊𝑎
𝑊𝑏
  
Where- Wb is weight of tablet before water absorption & Wa is 
weight of tablet after water absorption 
 
10) In vitro dissolution test: In vitro dissolution study has to 
be performed by using USP type II Apparatus (paddle 
type) [Electrolab ( ETC -11L) Tablet dissolution tester] at 
50 rpm. Phosphate buffer pH 6.8, 900 ml is mainly used as 
dissolution medium which is required to maintain at 
37±0.5°C. Aliquot of (10ml) dissolution medium is 
required to withdraw out at specific time interval (2min) 
and then it is required to subject for process of filtration. 
The amount of drug dissolved was determined by UV 
Spectrophotometer (Shimadzu, japan) by measuring the 
absorbance of the sample. Three trials of each batch were 
performed and average % drug release with standard 
deviation was calculated and recorded.  
 
11) Accelerated Stability study: The Orally disintegrating 
tablets are packed in suitable packaging and stored under 
the following conditions for a period as prescribed by ICH 
guidelines for accelerated studies.  
(i) 40 ± 1°C  
(ii) 50 ± 1°C  
(iii) 37 ± 1°C and Relative Humidity= 75% ± 5%  
 Withdraw the tablets after a period of 15 days and analyzed for 
physical characterization (Visual defects, Hardness, Friability, 
Disintegrations, and Dissolution etc.) and drug content. The 
data obtained is fitted into first order equations to determine the 
kinetics of degradation. Accelerated stability data are plotting 
according Arrhenius equation to determine the shelf life at 
25°C [15] 
 
Future Prospective for MDTs  
Now there are various products available commercially in 
market which is produced by fast dissolving tablet 
technologies. Still there is wide area for research on this 
technology. Some of the challenges like formulating a drug of 
bitter taste and moisture absorbing nature create problems for 
formulation scientist. When the dose of drug is large it causes 
problem of increased disintegration time. The two points to be 
considered in case of MDTs are shortening. Future prospective 
with continued innovations in pharmaceutical excipients, one 
can expect the emergence of more novel technologies for 
MDTs in the days to come. These innovations may involve 
modifying formulation composition and processing to achieve 
new performance end-points or the merger of new 
technological advances with traditional pharmaceutical 
processing techniques for the production of novel mouth 
dissolving dosage forms.  
It is reasonable to expect that future trends in innovations of 
drug delivery systems will continue to bring together different 
technological disciplines to create novel technologies.he 
disintegration time at the same time keeping other parameters 
like friability, taste, and mouth feel and tablet strength within 
the accepted range. Using taste masking agents and super-
disintegrating agents without significant increase in the weight 
& volume of final dosage forms. Also, there is a scope to 
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develop better packaging system to make FDTs more stable 
during handling. 
 
CONCLUSION  
The MDTs have potential advantages over conventional dosage 
forms, with their improved patient compliance, convenience, 
bioavailability and rapid onset of action had drawn the 
attention of many manufactures over a decade. MDTs 
formulations obtained by some of these technologies have 
sufficient mechanical strength, quick disintegration/dissolution 
in the mouth without water. There is a clear opportunity for 
new enhanced oral products arising within this market segment. 
Approximately one-third of the population, primarily the 
geriatric and pediatric populations, has swallowing difficulties, 
resulting in poor compliance with oral tablet drug therapy 
which leads to reduced overall therapy effectiveness.. These 
tablets are designed to dissolve or disintegrate rapidly in the 
saliva generally within <60 seconds (range of 5- 50seconds). 
The development of a fast-dissolving tablet also provides an 
opportunity for a line extension in the marketplace; a wide 
range of drugs (e.g., neuroleptics, cardiovascular drugs, 
analgesics, antihistamines, and drugs for erectile dysfunction) 
can be considered candidates for this dosage form. As a drug 
entity nears the end of its patent life, it is common for 
pharmaceutical manufacturers to develop a given drug entity in 
a new and improved dosage form. 
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